Quanto Agroworld IPO
Upcoming SMEAlready have an account? Apply now
Quanto Agroworld IPO details
Schedule of Quanto Agroworld
| Issue open date | 15 Sep 2026 |
| Issue close date | 17 Sep 2026 |
| UPI mandate deadline | 17 Sep 2026 (5 PM) |
| Allotment finalization | 18 Sep 2026 |
| Refund initiation | 21 Sep 2026 |
| Share credit | 21 Sep 2026 |
| Listing date | 22 Sep 2026 |
| Mandate end date | 02 Oct 2026 |
| Lock-in end date for anchor investors (50%) | 17 Oct 2026 |
| Lock-in end date for anchor investors (remaining) | 16 Dec 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Quanto Agroworld
Quanto Agroworld operates an integrated agricultural business focused on the cultivation of medicinal and aromatic plants alongside the processing of biomass and the extraction of essential oils through steam distillation. The company conducts its cultivation activities primarily on government and institutionally leased lands. Its core operations follow a farm-to-formulation model, covering land access, crop management, harvesting, and primary processing. To support these activities, the business reuses by-products generated during cultivation and distillation internally as compost, boiler fuel, and biomass-based inputs, thereby minimizing reliance on external third-party suppliers for raw materials. Quanto Agroworld primarily supplies its processed essential oils to institutional buyers, which include manufacturers operating within the pharmaceutical, fast-moving consumer goods, and fragrance industries.
Financials of Quanto Agroworld
Issue size
| Funds Raised in the IPO | Amount (₹ crores) |
| Total issue size | 31.02 |
| Fresh Issue – Proceeds go to the company | 31.02 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure for Distillation Plant at Rawalgaon |
3.79 (12.22%) |
| Capital Expenditure for the expansion of Farms | 15.23 (49.10%) |
| Repayment and/or prepayment of certain borrowings | 3.63 (11.70%) |
| Issue Expenses | 3.72 (11.99%) |
| General corporate purposes | 4.65 (14.99%) |
Strengths
- Integrated farm-to-formulation business execution model.
- Long-term relationships with pharmaceutical and FMCG clients.
- Scalable operations independent of external raw material suppliers.
- Highly experienced promoters and a capable management team.
- Zero-waste conversion of cultivation by-products into fuel.
Risks
- Complete geographic revenue concentration in Maharashtra and Gujarat.
- Vulnerable to adverse weather severely affecting crop yields.
- High revenue dependence on a few major institutional customers.
- Core cultivation and office operations rely on unowned, leased land.
- Past statutory non-compliances may attract regulatory penalties.